Navigation Links
Dr. Norman E. Rosenthal Joins Paul McCartney and David Lynch at Press Conference for Benefit Concert
Date:4/2/2009

Press conference preceding the David Lynch Foundation "Change Begins Within" benefit concert in New York to include local psychiatrist

BETHESDA, Md., April 2 /PRNewswire/ -- Dr. Norman E. Rosenthal will be among the distinguished speakers at a press conference on Friday, April 3 from noon to 1:00 pm EDT. Other speakers will include Paul McCartney, Ringo Starr, Russell Simmons and the concert sponsor, David Lynch. This news conference, which may be viewed online at http://www.davidlynchfoundation.org/, will launch the David Lynch Foundation's global initiative to teach one million at-risk youth to meditate. Funds for the initiative will be raised during the "Change Begins Within" benefit concert at Radio City Music Hall on Saturday, April 4.

Dr. Rosenthal is an internationally known psychiatrist and researcher, and medical director and CEO of Capital Clinical Research Associates in Bethesda. He will discuss his work using Transcendental Meditation (TM) for the treatment of combat-related Posttraumatic Stress Disorder (PTSD) in veterans of the conflicts in Iraq and Afghanistan, as well as for Bipolar Disorder. Dr. Rosenthal will point out, "TM's untapped potential for the multitudes or people afflicted by the pain and heartache of emotional disorders."

Dr. Rosenthal is the scientist who first described Seasonal Affective Disorder and pioneered the use of light therapy during his long career at the National Institute of Mental Health and author of Winter Blues and The Emotional Revolution.

About Capital Clinical Research Associates and the David Lynch Foundation

Capital Clinical Research Associates (CCRA) is a private clinical research center located in the North Bethesda/Rockville area in suburban
'/>"/>

SOURCE Capital Clinical Research Associates
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Unnecessary Spinal Surgery Will Waste Billions of Dollars in 2009 and Patients Will Continue to Suffer Unless the Primary Cause of Most Back Pain is Treated, Says Pain Specialist Norman Marcus, M.D.
2. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
3. SpongeTech(R) Delivery Systems, Inc. Clarification of Yesterdays $7,500,000 Order of Uncle Normans(TM) Pet Sponge
4. Secretary Norman Y. Mineta Joins Lung Cancer Alliance Board of Directors
5. Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D.
6. Institute for Integrative Nutrition, Joshua Rosenthal Attract Nations Top Health, Wellness Experts
7. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
8. Tomato Products Wellness Council Joins Harvard Medical School and the Culinary Institute of America to Take Part in Healthy Kitchen, Healthy Lives April 2-5, 2009
9. Eli Y. Adashi, MD, MS, FACOG, Joins Inverness Medical Innovations Board of Directors
10. Medical Device Industry Expert Matthew Jenusaitis Joins Avantis Medical Board of Directors
11. Traylor Joins LocumTenens.com as Medical Director-Psychiatry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco cosmetic ... CitiDent. CEREC is a newer method for creating restorations through innovative imaging equipment ... eliminating the need for multiple appointments, CEREC produces restorations with total precision for ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way ... , The patent-pending K Med Cups provide a quick and simple way to brew a ... cold, flu or cough. As a result, they enhance comfort and health. The invention features ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... taking place in Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & ... 2015 symposium are doctors and researchers at the top of their field and ...
(Date:9/4/2015)... ... ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and final ... meters final, with an impressive 44.89 seconds at the 2015 North American, Central American ... August 2015. The 44.64 time is a new NACAC Championship record. , Recent ...
(Date:9/4/2015)... ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... involving the Pope’s upcoming trip to the United States. , Yisrayl lays out what he ... the Vatican and society is. Yisrayl also provides the meaning of his own name and ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... , WASHINGTON, Aug. 31 As Congress prepares ... participating in at least 102 rallies and other events in ... a public health insurance option. , , ... the day Congress returns to Washington, D.C.. They are taking ...
... CHADDS FORD, Pa., Aug. 31 Endo Pharmaceuticals (Nasdaq: ENDP ) ... 2009 on Thursday, Sept. 10, 2009, at 2:40 p.m. EDT. Alan Levin, ... , , The presentation will be webcast live and can ... investors section. , , About Endo ...
... Aug. 31 A new study by Rand Corporation, published ... concludes retail clinics provide quality care at lower costs and ... study was based in part on data from MinuteClinic and ... to provide quality care and lower medical costs, MinuteClinic officials ...
... , , VENTURA, Calif., Aug. 31 ... than to receive." However, when the gift one is giving is ... with more than 97 percent organic aloe vera, receiving and giving ... Founded by Rinaldo and Lalla Brutoco, owners of the manufacturer ...
... , , , ... (the "Company") today announced that, at the Company,s 2009 Annual Meeting ... re-elect by an overwhelming majority all of the Company,s nominees to ... meeting were 63,725,589, representing approximately 56% of the 114,007,240 shares outstanding ...
... men, researchers say , MONDAY, Aug. 31 (HealthDay News) -- ... antigen (PSA) has led to mass over-diagnosis and over-treatment, a ... into use in 1986, federal government data show that the ... risen substantially, said the report in the Aug. 31 online ...
Cached Medicine News:Health News:'Let's Get it Done!' From Coast to Coast, USAction Affiliates Rally This Week for Quality, Affordable Health Care 2Health News:Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 2Health News:MinuteClinic Says Rand Corporation Study in Annals of Internal Medicine Study on Quality, Affordable Care at Retail Clinics Affirms Internal Information 2Health News:MinuteClinic Says Rand Corporation Study in Annals of Internal Medicine Study on Quality, Affordable Care at Retail Clinics Affirms Internal Information 3Health News:It's Better to Give Than to Receive 2Health News:It's Better to Give Than to Receive 3Health News:Healthcare Trust of America, Inc. Announces Results of 2009 Annual Meeting of Stockholders 2Health News:Healthcare Trust of America, Inc. Announces Results of 2009 Annual Meeting of Stockholders 3Health News:Prostate Cancer Over-Diagnosed: Study 2Health News:Prostate Cancer Over-Diagnosed: Study 3
(Date:9/4/2015)... , Sept. 4, 2015  PTC Therapeutics, Inc. ... five recipients of its first-ever global awards program, ... and Empowerment), designed to aid nonprofit organizations that ... (DMD) community. The announcement is made as the ... Duchenne Awareness Day on Monday, September 7, 2015. ...
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-nine. ... the Company, commented, "We believe our current pipeline of ...
(Date:9/4/2015)... , Sep. 04, 2015 ... http://www.researchandmarkets.com/research/dvzsqg/investigation ) has announced the addition of ... Hyaluronate Market, 2010-2019" report to their ... long-chain polymer containing repeating disaccharide units of ... fluid and cartilage matrix, sodium hyaluronate can ...
Breaking Medicine Technology:PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Investigation Report on China's Sodium Hyaluronate Market 2015 2
... - Peregrine's Selective Anti-VEGF Antibodies Inhibited Tumor Growth By, ... 90% In ... Inhibit VEGF Receptor,2 Could , Potentially Have Advantages over Non-Selective Approaches ... Fully Human,Antibody Support , Advancing Peregrine's Anti-VEGF Program towards Clinical Trials,- ...
... AACR Annual Meeting, BLOOMFIELD, N.J., April 16, 2007 ... and in vitro,preclinical data presented in a poster ... Meeting show that ONCONASE,(ranpirnase) significantly inhibits tumor growth ... cells. , In the poster titled "Increased apoptosis ...
Cached Medicine Technology:Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 2Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 3Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 4Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 5Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells 2Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells 3
... unique microprocessor controlled shaking incubator that accommodates ... or 384 well format. Speed, temperature and ... and all are displayed on the LCD. ... protective cover. The Millennium 2000 can be ...
Modular flow cytometer with all options....
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
... The IMMULITE 2000, a continuous random ... of 200 tests per hour, has ... and consolidation in medium- and high-volume ... with its self-explanatory graphical user interface, ...
Medicine Products: